HU196057B - Process for producing n,3-disubstituted 2-oxindolo-1-carboxamide derivatives - Google Patents

Process for producing n,3-disubstituted 2-oxindolo-1-carboxamide derivatives Download PDF

Info

Publication number
HU196057B
HU196057B HU851693A HU169385A HU196057B HU 196057 B HU196057 B HU 196057B HU 851693 A HU851693 A HU 851693A HU 169385 A HU169385 A HU 169385A HU 196057 B HU196057 B HU 196057B
Authority
HU
Hungary
Prior art keywords
formula
thienyl
oxindole
alkyl
phenyl
Prior art date
Application number
HU851693A
Other languages
German (de)
English (en)
Hungarian (hu)
Other versions
HUT37754A (en
Inventor
Saul B Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HUT37754A publication Critical patent/HUT37754A/hu
Publication of HU196057B publication Critical patent/HU196057B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU851693A 1984-05-04 1985-05-31 Process for producing n,3-disubstituted 2-oxindolo-1-carboxamide derivatives HU196057B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (2)

Publication Number Publication Date
HUT37754A HUT37754A (en) 1986-02-28
HU196057B true HU196057B (en) 1988-09-28

Family

ID=24431933

Family Applications (1)

Application Number Title Priority Date Filing Date
HU851693A HU196057B (en) 1984-05-04 1985-05-31 Process for producing n,3-disubstituted 2-oxindolo-1-carboxamide derivatives

Country Status (25)

Country Link
JP (1) JPS60243068A (fi)
KR (1) KR870000497B1 (fi)
AR (1) AR241159A1 (fi)
BG (2) BG60208B2 (fi)
CS (1) CS252828B2 (fi)
DD (1) DD232916A5 (fi)
EG (1) EG17193A (fi)
ES (2) ES8609248A1 (fi)
FI (1) FI80016C (fi)
HU (1) HU196057B (fi)
IE (1) IE851103L (fi)
IN (1) IN161509B (fi)
MA (1) MA20424A1 (fi)
MW (1) MW1685A1 (fi)
MX (1) MX5839A (fi)
NO (1) NO163132C (fi)
OA (1) OA08098A (fi)
PL (2) PL145416B1 (fi)
PT (1) PT80375B (fi)
RO (2) RO94455B (fi)
RU (1) RU2017729C1 (fi)
SU (1) SU1468413A3 (fi)
YU (1) YU44998B (fi)
ZA (1) ZA853324B (fi)
ZW (1) ZW7885A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis

Also Published As

Publication number Publication date
AR241159A1 (es) 1991-12-30
PL257892A1 (en) 1986-10-07
AR241159A2 (es) 1991-12-30
HUT37754A (en) 1986-02-28
PL147508B1 (en) 1989-06-30
FI851756L (fi) 1985-11-05
IN161509B (fi) 1987-12-19
CS252828B2 (en) 1987-10-15
DD232916A5 (de) 1986-02-12
PL145416B1 (en) 1988-09-30
KR870000497B1 (ko) 1987-03-12
JPH0335315B2 (fi) 1991-05-27
ES542813A0 (es) 1986-07-16
IE851103L (en) 1985-11-04
MX5839A (es) 1993-11-01
RO91141A (ro) 1987-06-30
YU44998B (en) 1991-06-30
RU2017729C1 (ru) 1994-08-15
CS320285A2 (en) 1987-03-12
PT80375A (en) 1985-05-01
ES8707182A1 (es) 1987-07-16
FI851756A0 (fi) 1985-05-03
MW1685A1 (en) 1986-09-10
BG60207B2 (en) 1993-12-30
RO91141B (ro) 1987-07-03
NO163132B (no) 1990-01-02
NO163132C (no) 1990-04-11
RO94455A (ro) 1988-06-30
ZA853324B (en) 1986-12-30
YU73085A (en) 1988-04-30
FI80016B (fi) 1989-12-29
MA20424A1 (fr) 1985-12-31
EG17193A (en) 1990-08-30
SU1468413A3 (ru) 1989-03-23
KR850008154A (ko) 1985-12-13
PL253203A1 (en) 1986-06-17
ES551275A0 (es) 1987-07-16
ES8609248A1 (es) 1986-07-16
OA08098A (fr) 1987-03-31
FI80016C (fi) 1990-04-10
ZW7885A1 (en) 1985-07-24
RO94455B (ro) 1988-07-01
JPS60243068A (ja) 1985-12-03
PT80375B (pt) 1987-09-30
BG60208B2 (en) 1993-12-30
NO851774L (no) 1985-11-05

Similar Documents

Publication Publication Date Title
CA1255658A (en) N, 3-disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
EP0156603B1 (en) 3-substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
EP0175551B1 (en) Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
DE69018553T2 (de) (Chinolin-2-ylmethoxy)-indole als Leukotrienbiosynthese-Hemmer.
EP0208510B1 (en) 1-substituted oxindole-3-carboxamines as antiinflammatory and analgesic agents
US4933336A (en) Thiadiazinone, oxadiazinone and triazinone derivatives, and their use for treating acute or chronic heart disease
US4721712A (en) 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
JPH0826018B2 (ja) アザオキシインドール誘導体
US4658037A (en) Intermediates for 1,3-disubstituted 2-oxindoles as analgesic and antiinflammatory agents
EP0153818B1 (en) 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
EP0155828B1 (en) Process for making 2-oxindole-1-carboxamides and intermediates therefor
HU196057B (en) Process for producing n,3-disubstituted 2-oxindolo-1-carboxamide derivatives
US4665194A (en) Process for making 2-oxindole-1-carboxamides and intermediates therefor
US4808601A (en) Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
DD232039A5 (de) Verfahren zur herstellung einer 2-oxinidol-1-carboxamid-verbindung
US4730004A (en) Analgesic and anti-inflammatory 1-acyl-2-oxindole-3-carboxamides
US4652658A (en) Process for making 2-oxindole-1-carboxamides and intermediates therefor
US4791131A (en) Analgesic and antiinflammatory 1-acyl-2-oxindole-3-carboxamides
CA1287626C (en) N-substituted 2-ixindole-1-carboxamides useful as intermediates for producing analgesic and antiinflammatory agents
HU194165B (en) Process for preparing 1,3-oxyacyl-2-oxindole derivatives
CA1255657A (en) 1,3-disubstituted 2-oxindoles as analgesic and anti- inflammatory agents
IE850288L (en) Analgesic oxindoles.
CA1289556C (en) 1- or 3-monosubstituted 2-oxindole compound intermediates useful for the production of analgesic and anti-inflammatory agents
CS252847B2 (cs) Způsob výroby N,3-disubstituovaných 2-oxindol-1-karboxamidů
BG60375B2 (bg) Заместени на 3-то място 2-оксиндол-1-карбоксамиди като аналгетични и противовъзпалителни вещества

Legal Events

Date Code Title Description
HU90 Patent valid on 900628